Found "Vaccines": 77 results
Sort by
Last updated

Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment

Summary The COVID-19 pandemic is unlikely to end until there is global roll-out of vaccines that protect against severe disease and preferably drive herd immunity. Regulators in numerous countries have authorised or approved COVID-19 vaccines for human use, with more expected to be licensed in 20

A systematic review of methodological approaches for evaluating real-world effectiveness of COVID-19 vaccines: Advising resource-constrained settings

Abstract Real-world effectiveness studies are important for monitoring performance of COVID-19 vaccination programmes and informing COVID-19 prevention and control policies. We aimed to synthesise methodological approaches used in COVID-19 vaccine effectiveness studies, in order to evaluate which

Cost-Effectiveness Analysis of COVID-19 Vaccine Booster Dose in the Thai Setting during the Period of Omicron Variant Predominance

The Thai government implemented COVID-19 booster vaccines to prevent morbidity and mortality during the spreading of the Omicron variant. However, little is known about which types of vaccine should be invested in as the booster dose for the Thai population. This study aims to investigate the most c

Economic Evaluation of Evusheld® for Preexposure Prevention of COVID-19 in High-Risk Populations: Early Evidence from Thailand

The introduction of Coronavirus disease 2019 (COVID-19) vaccines urged all Thais to seek prevention of serious illness and death from COVID-19. However, immunocompromised individuals might not be able to achieve an efficient immune response from these vaccines. This study aimed to evaluate the cost-

Would a rotavirus vaccination program for children under 5 years be cost-effective for Bhutan?

In many countries, rotavirus vaccination is the most cost-effective way to prevent rotavirus diarrhea. With this in mind, the Essential Medicines and Technology Division (EMTD) in collaboration with Health Intervention Technology Assessment Program (HITAP), Mahidol Oxford Research Unit (MORU), and P

Stepping up the campaign Against cervical cancer

The debate over the price of the vaccine against HPV has become intense When it comes to making the shot against cervical cancer the national vaccine programme, which means girls between the ages of 12-18 will receive it free, price is the matter.The debate over the price of the vaccine against Huma

Bird Flu Paper Is Published After Debate

The more controversial of two papers describing how the lethal H5N1 bird flu could be made easier to spread was published Thursday, six months after a scientific advisory board suggested that the papers’ most potentially dangerous data be censored.The paper, by scientists at Erasmus Medical Center i

The debate over the price of the vaccine against HPV has become intense

The debate over the price of the vaccine against HPV has become intenseWhen it comes to making the shot against cervical cancer the national vaccine programme, which means girls between the ages of 12-18 will receive it free, price is the matter.The debate over the price of the vaccine against Human

Bhutan’s oldest newspaper shows appreciation on iDSI’s support to evaluate new vaccines in Bhutan

Bhutan’s national and also the oldest newspaper named ‘Kuensel’ from the Kuensel Corporation Limited published a story featuring, our support to the Bhutanese government in evaluating new vaccines through an economic evaluation, in their issue of 28th August 2017 http://www.kuenselonline.com/moh-exp

China Health Technology Assessment (HTA) Hub

The past few years have seen significant progress in the development of Health Technology Assessment (HTA) in China. The China National Health Development Research Center (CNHDRC), the national focal point for HTA in China, has stepped up efforts to roll out HTA activities in many ways in order to s
10 / Page